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Abstract 
Bacterial therapies have been paid significant attentions by their ability to penetrate deep into the solid tumor tis‑
sue and its propensity to naturally accumulate in tumors of living animals. Understanding the actual mechanism for 
bacteria to target the tumor is therapeutically crucial but is poorly understood. We hypothesized that amino acids 
released from the specific tumors induced bacteria to those tumors and the experiments for chemotactic response of 
bacteria toward the cancer secreting amino acids was then performed by using the diffusion based multiple chemi‑
cal gradient generator constructed by in situ self‑assembly of microspheres. The quantitative analysis was carried out 
by comparison of intensity using green fluorescent protein (GFP) tagged Salmonella typhimurium (S. typhimurium) in 
the gradient generator, which showed the clear preference to the released amino acids, especially from breast cancer 
patients. The understanding chemotaxis toward the cancer secreting amino acids is essential for controlling S. typh-
imurium targeting in tumors and will allow for the development of bacterial therapies.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Bacteria have been considered as an alternative theranos-
tic activities to overcome the chemotherapeutics barrier 
[1–4]. The conventional therapy using anticancer drugs, 
which are capable of diffusing passively, are limited by 
their inability to penetrate into the tumor tissue and have 
poor cell susceptibility [1, 5, 6]. Moreover, the chemo-
therapy can be harmful to other types of normal cells in 
the process of treating cancer cell with side effects [4]. To 
date, the bacteria, which have the motile and easy genetic 
manipulation capability, could overcome the limitations 
by their ability to penetrate deep into the solid tumor tis-
sue and its propensity to naturally accumulate in tumors 
of living animals [1, 4]. Especially, Salmonella typhimu-
rium (S. typhimurium) has been drawn significant atten-
tions for the cancer therapies because several bacteria 
strains, such as Escherichia coli, Serratia marcescens, 
and Magnetotactic bacteria strains (Magnetospirillum 
gryphiswaldense strain MSR-1, Magnetospirillum mag-
netotacticum strain MS-1, Magnetospirillum magne-
ticum strain AMB-1, and Magnetococcus strain MC-1) 
have complex incubation procedure and drug resistance 
against antibiotics and pathogenicity in living animals 
[4, 7]. Recently, a number of researches have shown that 
the S. typhimurium preferentially accumulate 2000-fold 
more in tumors than in liver, spleen, lung, heart, and skin 
[1, 8, 9]. Moreover, because of propensity of S. typhimu-
rium to naturally accumulate in tumors of small living 
animals, particularly hypoxic tumors, the S. typhimurium 
for treatment and diagnosis of colorectal and breast can-
cers has been extensively studied [4, 8, 10–12].
Although the understanding an actual mechanism for 
bacteria to target the tumor is therapeutically crucial, 
the mechanisms of the bacterial motility toward tumors 
are unclear. Therefore, for further clinical applications, 
i.e., for effective bacterial therapies, it is important to 
investigate and clarify the actual mechanism by which 
bacteria target cancer. One of the possible mechanisms 
is the positive chemotaxis toward amino acids released 
from tumors. Tumors are known to possess and release 
the high concentration of amino acids, such as aspartate, 
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serine, alanine, glutamine, glutamate, and etc., compared 
with the surrounding normal tissues [13].
In this paper, we used the diffusion based multiple 
chemical gradient generations using in  situ self-assem-
bly of microspheres in microchannels [14] (see Fig.  1), 
to verify the chemotactic preference of S. typhimurium 
for the tumor secreting amino acids, especially for the 
breast cancer. Recently, many in vitro studies have shown 
the diffusion-based microfluidic devices for the chemical 
gradient generation. Specifically, the hydrogel membrane 
based microfluidic devices have been developed because 
hydrogels allow similar diffusion conditions to the water 
[14–17]. The most critical drawback of hydrogel mem-
ber based system, however, is that the hydrogels are not 
robust without an aqueous environment and the volume 
of the hydrogels can be changed significantly depending 
on the amount of the water absorption [14]. Moreover, 
the diffusion-based microfluidic devices which can gen-
erate the multiple chemical gradients have been devel-
oped [18–21]. Nevertheless, these devices have some 
drawbacks as comparing with the proposed device. In 
some cases, the devices were constructed with complex 
multilayered microfluidic parts so that it is complicated 
to fabricate the devices [18–20]. In other case, it is not 
easy to realize the spatio-temporal control of the chemi-
cal gradient direction [21].
In order to assess the chemotactic preference of S. 
typhimurium for the breast cancer, the reference val-
ues of amino acid concentration in serum from breast 
cancer patients and healthy donors were sought firstly 
and among these amino acids, the lowest values of the 
threshold concentration (concentration of attractant 
that induces an accumulation of bacteria in the capil-
lary significantly greater than that obtained absence of 
attractant) were then chosen. Next, the amino acids were 
introduced simultaneously into the gradient generation 
device to mimic the surround environment of the tumor. 
Lastly, the quantitative analysis of S. typhimurium prefer-
ence for human breast tumor secreting amino acids was 
performed. We believe that this understanding chemot-
axis toward the cancer secreting amino acids is essential 
for controlling S. typhimurium targeting in tumors and 
will allow for the development of bacterial therapies.
Methods
Fabrication process of PDMS microfluidic channel
Figure  2a shows schematic diagrams that describe the 
procedures for fabricating microfluidic devices with 
multilayered design as we previously reported [14]: The 
negative photoresist (SU-8 2025, Microchem Corp.) was 
pipetted on top of the 4-inch silicon wafer and was then 
spin-coated to form the first layer, i.e. the shallow channel. 
The spin coated silicon wafer was then soft-baked for sev-
eral minutes. Subsequently, the wafer was exposed under 
a mask using an MA-6 aligner (Karl-suss, Germany) 
and was then placed on a hot-plate for several minutes 
of post-exposure baking, followed by a short relaxation 
time. Then the pattern was developed in SU-8 developer. 
SU-8 2050 was then patterned onto the first SU-8 layer 
for the second layer, i.e., deep channel, as the same pro-
cess as above. Next, the SU-8 patterned silicon master was 
silanized with (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-
1-trichlorosilane (Sigma Chemical Co., St. Louis, MO, 
USA) to reduce adhesion between the master and the 
newly fabricated polydimethylsiloxane (PDMS) based 
microfluidic devices. A 10:1 PDMS base to curing agent 
(Sylgard 184, Dow Corning) mixture was then poured to 
cover the SU-8 patterned silicon master and the PDMS 
was cured at 95 °C for 1 h. After the cured PDMS chan-
nel was peeled off from the master, cutting into the each 
Fig. 1 Schematic representation of the multiple chemical gradients generator for in vitro assay for bacterial preference toward cancer secreting 
amino acids. 3D view (a) and top view (b) of the device
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device and punching the inlet and outlet was followed. 
Finally, the PDMS devices and a slide glass were plasma 
treated (50 sccm of O2 and 70 W) for 40 s in an O2 plasma 
machine (Cute-MP, Femto Science, Korea) and were then 
bonded each other to form the microfluidic channels.
In situ formation of microchannel networks using 
microparticles
Figure 2c shows the time sequence microscopic images for 
a formation of the microchannel networks using micro-
spheres within the shallow channel, as reported previ-
ously [14, 22–25]. The PDMS device with shallow channel 
and deep channels (source/sink channel and center cham-
ber) were fabricated as shown in Fig. 2b. The diluted silica 
microspheres with diameter of 1  μm (Polyscience Inc., 
Warrington, USA) in 70  % ethanol (v/v) were then intro-
duced into the source channel (deep channel) by capillary 
pressure. The diluted microspheres at the interface between 
shallow and deep channel experience a sudden pressure 
drop, which tries to drag the solution in the deep channel 
into the shallow channel [26]. The diluted microspheres at 
the intersection between shallow and source channel (deep 
channel) experience a sudden pressure drop (ΔP12), which 
tries to drag the solution in the deep channel into the shal-
low channel (Fshallow) [26]. When this flow of solution in 
shallow channel is located at the neck (interface between 
the shallow channel and the cell chamber i.e., deep chan-
nel), the pressure difference (ΔPn) between inside (Pa) and 
outside (P0) the solution is induced and it can be expressed 
as below [27]:
Fig. 2 Multiple chemical gradients generator for in vitro chemotaxis assay. a Schematic illustrations of fabrication process for multi‑height PDMS 
microfluidic channels. b Microscopic images of fabricated multi‑height PDMS microfluidic channels. c Time sequence microscopic images for 
in situ formation of microspheres assembly within the shallow channel. d Picture of fabricated device and its magnified microscopic images. e 
Fluorescence images of generated FITC gradients to the three different directions. f Representative plots for corresponding normalized fluorescence 
intensity
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where, σ, hs, and ws is the surface tension, the height 
of shallow channel, and the width of shallow channel, 
respectively. θ is the contact angle and the subscripts T, 
B, L, and R indicate the top, bottom, left and right surface 
of the shallow channel, respectively. β is the expansion 
angle in the width direction. In these equations, the solu-
tion may move forward toward the deep channel-B when 
the capillary pressure at the neck, ΔPn, is positive, and 
stop at the neck when ΔPn is negative. In this paper, β of 
90° and the value of the surface tension with 0.025 N/m 
was used for 70 % ethanol [28]. In addition, the contact 
angles were measured from the PDMS substrate (for θT, 
θL, and θR, ~60°) and glass substrate (for θB, ~45°). As a 
result, the capillary stop pressure at the neck is induced 
and the solution could not move forward toward the cell 
chamber (deep channel). After the solution stop at the 
neck, the evaporation of the solvent happened through 
the cell chamber. Then the convective transport of micro-
spheres was caused from the source channel toward 
the neck to compensate of the solvent loss by evapora-
tion. This influx of the microspheres then promotes the 
growth of the ordered lattice (FCC structure) from neck 
to the source channel in unidirectional. When the growth 
of microspheres assembly reached the interface between 
the shallow channel and the source channel, the residual 
solution in source channel was gently removed by with-
drawing. Finally, self-assembled microspheres were dried 
out in room temperature for 1 day. The micro-interstices 
formed in these closed-packed microspheres of homo-
geneous sizes, which consist of equivalent micropores 
(~15  % of the sphere size) [29], serve as the diffusion 
channels.
Preparation of bacteria cells
Engineered attenuated S. typhimurium defective in 
guanosine 5′-diphosphate-3′-diphosphate (ppGpp) syn-
thesis (ΔppGpp strain) used to express the bacterial lucif-
erase gene lux for generating imaging signals was used 
in a chemotaxis experiment [14, 30]. Cells were cultured 
overnight in 5 mL of Luria–Bertani (LB) medium (Fisher, 
Pittsburgh, PA, USA) supplemented with 50 μg/mL ampi-
cillin and kanamycin at 37 °C in an incubator with shak-
ing at 200 rpm. A 1 % culture of the bacterial solution in 
LB medium containing ampicillin and kanamycin was 
prepared. Then, cells were incubated in a shaking incuba-
tor (37  °C, 200 rpm) for 3–4 h until the 600 nm optical 
density (OD600) of the cell culture reached 1.0. Finally, the 
cells were centrifuged at 3000 rpm at room temperature 
and resuspended in M9 medium (minimal salt, BD, NJ, 
(1)
�Pn = Pa − P0
= −σ
(
cos θT + cos θB
hs
+
cos(θL + β)+ cos(θR + β)
ws
) USA.) containing the 10−3 M of glucose. M9 medium is used for making minimal media so that it can provide 
the basic ionic buffering for the cells, and also provide 
an environment with comfortable osmotic properties. 
Therefore, bacteria can be grown until they are cultured 
in LB medium and they can maintain their population in 
M9 medium. From this, we can suppress an error which 
resulted from the increase of bacterial populations dur-
ing reacting with amino acids. Before cells were loaded, 
the cell chamber was coated for 2  h with Pluronic sur-
factant (F-127, 1 %, Sigma-Aldrich, St. Louis, MO, USA) 
to minimize any nonspecific binding between the cells 
and the glass surface and subsequently rinsed with M9 
medium. Finally, the prepared cell suspension was loaded 
into the cell chamber.
Experimental setup and data analysis
FITC fluorescence dye diluted in M9 medium was used 
to characterize the proposed microfluidic device. For the 
amino acids, α-methyl-DL-aspartic acid and l-arginine 
were purchased from Sigma-Aldrich, USA, and l-seine 
and l-alanine were purchased from Daejung Chemi-
cals & Metals, Korea. All amino acids were diluted in 
M9 medium before using as sources for chemoattract-
ant. The fluorescence intensities could be quantitatively 
assessed from the captured images using ImagePro Plus 
(MediaCybernetics, Bethesda, MD, USA) software. A 
precise microsyringe pump (NE-1000, New Era Pump 
System, USA) was employed to control the flow rate in 
the source/sink channel through the microtubes. The 
cells behavior was monitored using an inverted micro-
scope (IX7, Olympus Co., Tokyo, Japan) and images were 
captured using a CCD camera (CoolSNAP, Photome-
trices, Tucson, AZ, USA) installed in the microscope. To 
quantify the cell count, the same method was used as our 
previously published paper [14]. Briefly, same amounts of 
drops containing GFP-expressing S. typhimurium with 
different normalized concentrations were loaded into the 
open-cylinder type reservoir and the numbers of cells 
were calibrated by analyzing the fluorescent intensity. 
Finally, the fluorescent intensities at three different areas 
in the cell chamber were measured and then converted 
into the number of cells. For all statistical tests, analysis 
was performed using SigmaPlot software, and a p value 
of <0.05 was considered significant. All data is presented 
as the mean ± the standard error of the mean (SEM).
Results and discussions
The picture of the fabricated PDMS microfluidic chan-
nels with microchannel networks membrane (MCNM) 
and an enlarged microscopic image around the center 
chamber are shown in Fig. 2d. The source channels and 
the cell chamber are isolated by the MCNM. In order to 
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characterize the device, the diffusivity of MCNM was 
tested using fluorescence dye (FITC). First, the base 
solution (M9 medium) was filled into the whole device. 
The fluorescence dye was then introduced into the three 
source channel (90°, 210°, and 330°). Subsequently, the 
flow rate of 4.0  μL/min was controlled by withdrawing 
the solution to maintain the concentration. Finally, the 
stable concentration of FITC was established across the 
cell chamber in the three different directions because 
there was no net flow in the cell chamber but there was 
the diffusion of fluorescence dyes through the MCNM. 
Figure  2e shows the fluorescence images at the steady-
state and Fig. 2f shows one of representative plots of the 
normalized fluorescence intensity profiles across the cell 
chamber as a function of time. The steady-state gradi-
ents were established within 1 min and were maintained 
for several minutes. In this paper, the proposed device 
was suitable for the chemotactic study for bacterial 
cells because S. typhimurium showed the chemotactic 
response toward the amino acids within 80 s.
To demonstrate the capability of chemotaxis study 
using the proposed device, the behavior of S. typhimu-
rium toward the single amino acid was observed. The 
l-arginine was injected into the source channel at 90° 
and M9 medium was introduce at the others and the flow 
was then controlled by withdrawing the solution to main-
tain the solution concentration in source/sink channels. 
Finally, bacterial cells were loaded into the cell chamber 
and images were then acquired for 60  s. As a result, S. 
typhimurium showed the positive response to the l-argi-
nine in the presence of the concentration of 250  mM 
(Fig. 3).
In order to verify a chemotactic preference of S. typh-
imurium when exposed the multiple cancer secret-
ing amino acids, the reference values of amino acid 
concentration in serum from breast cancer patients and 
healthy donors were investigated [13]. Among these 
amino acids, the aspartate, the serine, and the alanine 
were chosen, which have lowest values of the threshold 
concentration (concentration of attractant that induces 
an accumulation of bacteria in the capillary significantly 
greater than that obtained absence of attractant) as pre-
vious studies showed [31]. Table  1 shows the reference 
values of threshold concentration of amino acid [31] and 
secreted concentration from health donors and breast 
cancer patients [13].
As shown in Fig.  4a, serine (1.60  mM), aspartate 
(0.17  mM), and alanine (6.42  mM) diluted in M9 
medium were introduced into the each source channel 
at 90°, 210°, and 330°, respectively. The concentrations of 
amino acids were determined by reference values of the 
breast cancer patients shown in Table 1. 50 s after load-
ing the S. typhimurium into the cell chamber, bacterial 
Fig. 3 Time sequence images for response of GFP‑tagged S. typhimurium toward l‑arginine. Bacterial cells show the positive response to the 
l‑arginine with the concentration of 250 mM
Table 1 Threshold concentration of  amino acid 
and secreted concentration from health donors and breast 
cancer patients
a Reference values from the Adler capillary assay [31]










Aspartate ~0.002 ~0.11 ~0.17
Serine ~0.002 ~1.32 ~1.60
Alanine ~0.002 ~3.92 ~6.42
Glutamine ~0.1 ~2.69 ~3.91
Glutamate ~0.004 ~0.59 ~1.08
Aspargine ~0.01 ~0.36 ~0.41
Arginine ~1 ~0.71 ~0.93
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cells showed the strongest positive chemotactic response 
toward the aspartate despite having a lowest concentra-
tion. Furthermore, by quantifying the changing the num-
ber of cells (Δcells), S. typhimurium seems sensitive to 
the aspartate, serine and alanine, in this manner. Here, 
three amino acids were compared using one-way analy-
sis of variance (ANOVA), with Tukey’s post hoc tests for 
multiple comparisons (n  =  6, mean  ±  SEM, *:  <0.001, 
**: =0.007).
To confirm this preference, the experiment for the 
chemotactic response toward the aspartate versus the 
serine was performed as shown in Fig.  4b. The serine 
(1.60  mM) and the aspartate (0.17  mM) diluted in M9 
medium were injected into the source channel at 90° 
and 270°, respectively, and the bacterial cells were then 
loaded into the center chamber. Each concentration of 
amino acid was the same as breast cancer patients shown 
in Table  1. Consequently, the quantitatively counted 
Fig. 4 Time sequence images for response of S. typhimurium toward representative cancer secreting amino acids and its corresponding bar plots for 
the changing of the number of cells. a Chemotactic response towards aspartate, serine and alanine with concentration values from breast cancer 
patients. b Chemotactic response towards aspartate and serine with concentration values from breast cancer patients. c Chemotactic response 
towards aspartate with concentration value from normal human versus breast cancer patients. Mean ± SEM, *: <0.001, **: =0.007
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cells data reveals that the aspartate is most sensitive 
chemoattractant for the S. typhimurium (t tests, n =  6, 
mean ± SEM, *: <0.001).
Finally, the bacterial preferential behavior against the 
released aspartate concentration from breast cancer 
patients and healthy donors were investigated. The aspar-
tate concentrations of 0.11 and 0.17  mM were chosen 
for health donors and cancer cell patients, respectively 
[13]. As shown in Fig. 4c, S. typhimurium showed strong 
positive chemotactic response toward the concentration 
gradient of aspartate at the cancer patient level (t tests, 
n = 6, mean ± SEM, *: <0.001). This result shows the pos-
sibility that the concentration gradients of released aspar-
tate from tumor can be crucial for targeting the tumor by 
S. typhimurium. Moreover, these results are reasonable 
as comparing with in  vitro experiment by using tumor 
cylindroids model and S. typhimurium which individual 
chemoreceptors were knockout [1]. The results showed 
that the aspartate receptor initiated chemotaxis toward 
tumor cylindroids, the serine receptor initiated penetra-
tion, and the ribose/galactose receptor directed S. typh-
imurium toward necrosis. Previously, we demonstrated 
that the S. typhimurium showed more strong response 
toward the aspartate than to the ribose/galactose [2], the 
results altogether, therefore, the aspartate could be the 
one of the essential role for targeting S. typhimurium to 
the specific tumors.
Conclusions
The chemotactic preference of S. typhimurium for the 
tumor secreting amino acids, especially for the breast 
cancer was investigated. The candidate amino acids with 
the specific concentration values from breast cancer 
patients were introduced simultaneously into the multi-
ple chemicals gradients generator which was constructed 
by spatially controlled self-assembly of particles in micro-
channels. After quantitative analyzing the chemotactic 
motion of S. typhimurium, we could conclude that S. 
typhimurium has strongest responsive toward the aspar-
tic acid. This understanding chemotactic response to the 
cancer secreting amino acids will allow the development 
of bacterial therapies by utilizing the drug producible 
engineered bacteria or the bacteria-based micro-robot 
(bacteriobot) [3, 4, 32, 33] as enhancing the speed and 
precisely controlling the direction of bacteria.
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